» Articles » PMID: 2429422

Latent Carcinoma and Atypical Lesions of Prostate. An Autopsy Study

Overview
Journal Urology
Specialty Urology
Date 1986 Oct 1
PMID 2429422
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

The posterior lobe of the prostate of 180 consecutive autopsies was examined by the step section method. Latent carcinoma was found in 25 per cent of the prostates examined, with an increasing frequency according to age. Atypical lesions were seen in 153 of 180 prostates (85%) and were significantly more frequent and extensive in patients with rather than without latent carcinoma. Latent carcinoma was more extensive either when grade 2 histologically or when showing cribriform arrangement. There was no relationship of latent carcinoma to nodular hyperplasia or extraprostatic cancer. Atypical lesions were not significantly more extensive in patients with large latent carcinomas than in those with small ones. Atypical lesions als showed no significant increase in frequency according to age. The findings support the concept that atypical lesions may represent a potentially precancerous lesion.

Citing Articles

Global Trends of Latent Prostate Cancer in Autopsy Studies.

Kimura T, Sato S, Takahashi H, Egawa S Cancers (Basel). 2021; 13(2).

PMID: 33478075 PMC: 7835858. DOI: 10.3390/cancers13020359.


Does obesity modify prostate cancer detection in a European cohort?.

Sanchis-Bonet A, Morales-Palacios N, Barrionuevo-Gonzalez M, Ortega-Polledo L, Ortiz-Vico F, Sanchez-Chapado M Cent European J Urol. 2017; 70(1):30-36.

PMID: 28461985 PMC: 5407327. DOI: 10.5173/ceju.2017.881.


Prostate cancer: is it time to expand the research focus to early-life exposures?.

Sutcliffe S, Colditz G Nat Rev Cancer. 2013; 13(3):208-518.

PMID: 23363989 PMC: 3962783. DOI: 10.1038/nrc3434.


Epidemiology of prostate cancer and treatment remarks.

Arcangeli S, Pinzi V, Arcangeli G World J Radiol. 2012; 4(6):241-6.

PMID: 22778875 PMC: 3391668. DOI: 10.4329/wjr.v4.i6.241.


Prognostic value of a cell cycle progression signature for prostate cancer death in a conservatively managed needle biopsy cohort.

Cuzick J, Berney D, Fisher G, Mesher D, Moller H, Reid J Br J Cancer. 2012; 106(6):1095-9.

PMID: 22361632 PMC: 3304411. DOI: 10.1038/bjc.2012.39.